Loading...
A Randomized, Multicenter, Phase II Study of Cetuximab With Docetaxel and Cisplatin as Induction Chemotherapy in Unresectable, Locally Advanced Head and Neck Cancer
LESSONS LEARNED: Addition of cetuximab may affect tolerability and, in turn, affect eventual outcomes. The incidence of prior human papillomavirus infection has emerged as an important variable that can confound trials enrolling patients with oropharyngeal cancer. BACKGROUND. We investigated the eff...
Na minha lista:
| Udgivet i: | Oncologist |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
AlphaMed Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4591951/ https://ncbi.nlm.nih.gov/pubmed/26304911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0208 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|